Skip to main content
Premium Trial:

Request an Annual Quote

Gentel Biosciences Licenses Agnitio's Coating Technology for Protein Arrays

NEW YORK (GenomeWeb News) – Gentel Biosciences said yesterday that it has licensed technology from Agnitio Science and Technology of Hsinchu, Taiwan, covering the use of an ultrasonic coating used in producing nitrocellulose films.
The Madison, Wisconsin-based Gentel said it will use the ultrasonic coating technology to manufacture “highly reproducible” nitrocellulose protein microarray slides. The company said it will incorporate the technology into its manufacturing process for its standard microarray slides as well as for its APiX 96-well microarray platform.
G. Randall Durnell, VP of commercial operations at Gentel, said in a statement that the platform will enable the company to “to manufacture the number and type of protein microarray slides required for protein biomarker discovery, validation, and diagnostics.”
The company said that ultrasonic coating produces nitrocellulose films with a consistency that is “unattainable using traditional coating processes like casting.”
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.